Therefore, the correlation of CD39, CTLA-4, TIGIT, TIM-3, and TNFR2 with Ki-67 suggested that their overexpression in Treg and/or exhausted CD8+ T cells of patients with ALL favors leukemia development and treatment resistance. This evidence concerns the gene ENTPD1 and leukemia.